Thanks for the report. Excellent unbiased. Even gave Lovaza some spotlight and how Vascepa is NOT a "Fish Oil." It''s a molecule within Fish oil. I also like discussion on where fish get EPA (from Marine Algae). Something Kaylawa was alluding to with Slanmhor Pharmaceuticals Inc. and their JV development partner in Australia. If a Marine algae based EPA manufacturing methodology can be developed then this would be a home run for all.
Sentiment: Strong Buy
That's fantastic!! Almost 300 new scripts from last week! That's six (6) new scripts for the week for every State in the Union! Approximately one (1) new script from last week for every 275 reps we have!! These guys are really producing, that's for sure. This GIA strategy is going to re-write history. To the Moon Alice as Jackie Gleason used to say!!
Yo dude. That's over 1000 new scripts from last week, not almost 300. Also dude do you think that symphony and ims survey data is going to do a good job at targeting the highest prescribing docs that amrn sales force is focused on. Do you think that dude?
goin, as we both said before it really will take 6m to 1 year to see where its all heading as to scripts at least for the marine indication. short term i see the ob update as a near term catalysts, williams did find some interesting information that can be interpreted to suggest maybe a decision this go around. All my bios were up today so no complaints ;-)